An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity

[1]  Brandy E. Olin,et al.  Innate cell microenvironments in lymph nodes shape the generation of T cell responses during type I inflammation , 2021, Science Immunology.

[2]  D. Lingwood,et al.  Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines , 2021, Vaccines.

[3]  D. Lauffenburger,et al.  Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques , 2020, Nature.

[4]  Derek T O'Hagan,et al.  The continued advance of vaccine adjuvants - 'we can work it out'. , 2020, Seminars in immunology.

[5]  M. Nussenzweig,et al.  Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo , 2020, The Journal of experimental medicine.

[6]  E. Walsh,et al.  Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates , 2020, The New England journal of medicine.

[7]  N. Hacohen,et al.  Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity , 2020, Science.

[8]  M. Beltramello,et al.  Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms , 2020, Science.

[9]  Lisa E. Gralinski,et al.  A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice , 2020, Cell.

[10]  V. Shinde,et al.  Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine , 2020, The New England journal of medicine.

[11]  Rebecca J. Loomis,et al.  Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates , 2020, The New England journal of medicine.

[12]  D. Lauffenburger,et al.  Single-Shot Ad26 Vaccine Protects Against SARS-CoV-2 in Rhesus Macaques , 2020, Nature.

[13]  M. Chen,et al.  A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction , 2020, Nature Biotechnology.

[14]  Lisa E. Gralinski,et al.  Potently neutralizing and protective human antibodies against SARS-CoV-2 , 2020, Nature.

[15]  J. Mascola,et al.  An mRNA Vaccine against SARS-CoV-2 — Preliminary Report , 2020, The New England journal of medicine.

[16]  D. Irvine,et al.  Controlling timing and location in vaccines , 2020, Advanced Drug Delivery Reviews.

[17]  D. Burton,et al.  Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model , 2020, Science.

[18]  Larissa B. Thackray,et al.  A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies , 2020, Cell.

[19]  Z. Rao,et al.  Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody , 2020, Science.

[20]  A. Luster,et al.  Targeting Lymph Node Niches Enhances Type 1 Immune Responses to Immunization , 2020, Cell reports.

[21]  William J. Liu,et al.  A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2 , 2020, Nature.

[22]  X. Xie,et al.  Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells , 2020, Cell.

[23]  Barney S. Graham,et al.  Rapid COVID-19 vaccine development , 2020, Science.

[24]  Andrea J. Radtke,et al.  The lymph node at a glance – how spatial organization optimizes the immune response , 2020, Journal of Cell Science.

[25]  Young-Jun Park,et al.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[26]  Daniel W. Kulp,et al.  Engineered immunogen binding to alum adjuvant enhances humoral immunity , 2020, Nature Medicine.

[27]  B. Graham,et al.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.

[28]  F. Granucci,et al.  Cellular and molecular mechanisms of antifungal innate immunity at epithelial barriers: The role of C‐type lectin receptors , 2020, European journal of immunology.

[29]  P. Tailor,et al.  RelB suppresses type I Interferon signaling in dendritic cells. , 2020, Cellular immunology.

[30]  I. Amit,et al.  Spatiotemporal regulation of type I interferon expression determines the antiviral polarization of CD4+ T cells , 2020, Nature Immunology.

[31]  Ren-Huan Xu,et al.  Langerhans Cells Orchestrate the Protective Antiviral Innate Immune Response in the Lymph Node , 2019, Cell reports.

[32]  J. Kagan,et al.  Inflammasomes: Threat-Assessment Organelles of the Innate Immune System. , 2019, Immunity.

[33]  L. Ivashkiv,et al.  Interferon target-gene expression and epigenomic signatures in health and disease , 2019, Nature Immunology.

[34]  Stefano Monti,et al.  hypeR: An R Package for Geneset Enrichment Workflows , 2019, bioRxiv.

[35]  K. Crozat,et al.  Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How? , 2019, Front. Immunol..

[36]  Avital Lev,et al.  Migratory Dendritic Cells, Group 1 Innate Lymphoid Cells, and Inflammatory Monocytes Collaborate to Recruit NK Cells to the Virus-Infected Lymph Node. , 2018, Cell reports.

[37]  L. Ivashkiv.  IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy , 2018, Nature Reviews Immunology.

[38]  Gordon D. Brown,et al.  C-type lectins in immunity and homeostasis , 2018, Nature Reviews Immunology.

[39]  Xueqiang Zhao,et al.  CARD9S12N facilitates the production of IL-5 by alveolar macrophages for the induction of type 2 immune responses , 2018, Nature Immunology.

[40]  O. Levy,et al.  Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life Immunization , 2017, Front. Immunol..

[41]  F. Granucci,et al.  Skin infections are eliminated by cooperation of the fibrinolytic and innate immune systems , 2017, Science Immunology.

[42]  R. A. van den Berg,et al.  Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity , 2017, npj Vaccines.

[43]  Shao-Cong Sun.  The non-canonical NF-κB pathway in immunity and inflammation , 2017, Nature Reviews Immunology.

[44]  T. Hohl,et al.  Immunity against fungi. , 2017, JCI insight.

[45]  S. Acton,et al.  Dendritic cells in remodeling of lymph nodes during immune responses , 2016, Immunological reviews.

[46]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[47]  M. Shlomchik,et al.  Sequential Activation of Two Pathogen-Sensing Pathways Required for Type I Interferon Expression and Resistance to an Acute DNA Virus Infection. , 2015, Immunity.

[48]  Michael Y. Gerner,et al.  In vivo characterization of the physicochemical properties of TLR agonist delivery that enhance vaccine immunogenicity , 2015, Nature Biotechnology.

[49]  S. Elledge,et al.  Comprehensive serological profiling of human populations using a synthetic human virome , 2015, Science.

[50]  Sky W. Brubaker,et al.  Innate immune pattern recognition: a cell biological perspective. , 2015, Annual review of immunology.

[51]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[52]  Robert P. Jenkins,et al.  Dendritic Cells Control Fibroblastic Reticular Network Tension and Lymph Node Expansion , 2014, Nature.

[53]  B. Lambrecht,et al.  Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells , 2014, The Journal of Immunology.

[54]  Gregory L. Szeto,et al.  Structure-based programming of lymph-node targeting in molecular vaccines , 2014, Nature.

[55]  M. Netea,et al.  Novel Structural Features in Candida albicans Hyphal Glucan Provide a Basis for Differential Innate Immune Recognition of Hyphae Versus Yeast* , 2013, The Journal of Biological Chemistry.

[56]  Changying Jiang,et al.  C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. , 2013, Immunity.

[57]  Ronald N. Germain,et al.  A Spatially-Organized Multicellular Innate Immune Response in Lymph Nodes Limits Systemic Pathogen Spread , 2012, Cell.

[58]  K. Knagge,et al.  Mannan structural complexity is decreased when Candida albicans is cultivated in blood or serum at physiological temperature. , 2011, Carbohydrate research.

[59]  David L. Williams,et al.  C. albicans increases cell wall mannoprotein, but not mannan, in response to blood, serum and cultivation at physiological temperature. , 2011, Glycobiology.

[60]  S. Turley,et al.  Reproducible Isolation of Lymph Node Stromal Cells Reveals Site-Dependent Differences in Fibroblastic Reticular Cells , 2011, Front. Immun..

[61]  Jun Ma,et al.  Activation of the innate immune receptor Dectin-1 upon formation of a “phagocytic synapse” , 2011, Nature.

[62]  Martin F. Bachmann,et al.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.

[63]  S. Gringhuis,et al.  Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk , 2009, Nature Immunology.

[64]  Richard A. Flavell,et al.  Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants , 2008, Nature.

[65]  Yasunobu Miyake,et al.  Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. , 2007, The Journal of clinical investigation.

[66]  P. Borrow,et al.  A role for the transcription factor RelB in IFN‐α production and in IFN‐α‐stimulated cross‐priming , 2006 .

[67]  Akiko Iwasaki,et al.  Innate control of adaptive immunity via remodeling of lymph node feed arteriole. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[68]  R. Geahlen,et al.  Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid. , 2005, Vaccine.

[69]  Antonio Lanzavecchia,et al.  Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming , 2004, Nature Immunology.

[70]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[71]  T. Blankenstein,et al.  CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. , 2004, Immunity.

[72]  H. Yonekawa,et al.  Diphtheria toxin receptor–mediated conditional and targeted cell ablation in transgenic mice , 2001, Nature Biotechnology.

[73]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[74]  T. Phan,et al.  Subcapsular Sinus Macrophages: The Seat of Innate and Adaptive Memory in Murine Lymph Nodes. , 2019, Trends in immunology.

[75]  Mark D. Robinson,et al.  Differential analyses for RNA-seq : transcript-level estimates improve gene-level inferences Supplementary Material , 2015 .

[76]  M. Netea,et al.  An integrated model of the recognition of Candida albicans by the innate immune system , 2008, Nature Reviews Microbiology.

[77]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[78]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.